Remarkably, the patients diagnosed with both cancers showed a 50% rate of mutation detection (Table 1), again with similar distribution in both genes: 69% detected in BRCA1, 27.6% in BRCA2, and 3.4% in both genes. The gene discussed is BRCA2; the disease is cancer.